Shanrong Biotechnology Corp
Shanrong Biotechnology Corp. does not have significant operations. Previously, it was operated as a project management and executive consulting company. The company was formerly known as Defense Solutions Holding, Inc. and changed its name to Shanrong Biotechnology Corp. in September 2017. Shanrong Biotechnology Corp. is based in Torrance, California.
Shanrong Biotechnology Corp (SRBT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.081x
Based on the latest financial reports, Shanrong Biotechnology Corp (SRBT) has a cash flow conversion efficiency ratio of 0.081x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.75K) by net assets ($-107.48K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanrong Biotechnology Corp - Cash Flow Conversion Efficiency Trend (2008–2022)
This chart illustrates how Shanrong Biotechnology Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanrong Biotechnology Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanrong Biotechnology Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SPIFFBET AB
F:2AK
|
N/A |
|
CHOICE PROPERTIES REIT
F:6HC
|
N/A |
|
Middle & West Delta Flour Mills
EGX:WCDF
|
N/A |
|
Dongbu Securities Co. Ltd.
KQ:016610
|
N/A |
|
IVANHOE MINES-A
BE:IYAA
|
-0.006x |
|
HEXAGON -B- - Dusseldorf Stock Exchang
DU:HXGB
|
0.031x |
|
BlackRock Long-Term Municipal Advantage Trust
NYSE:BTA
|
0.021x |
|
ENSPF
PINK:ENSPF
|
N/A |
Annual Cash Flow Conversion Efficiency for Shanrong Biotechnology Corp (2008–2022)
The table below shows the annual cash flow conversion efficiency of Shanrong Biotechnology Corp from 2008 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-78.98K | $-77.17K | 0.977x | +20.66% |
| 2017-12-31 | $-39.21K | $-31.75K | 0.810x | +309.24% |
| 2009-12-31 | $-3.98 Million | $-787.42K | 0.198x | -50.35% |
| 2008-12-31 | $-3.65 Million | $-1.46 Million | 0.399x | -- |